Aetna and the Aetna Foundation Award $2.25 Million in Grants to
dBusinessNews.com - We are delighted to fund programs with the potential to serve as national models for improving end-of-life care and depression treatment,” said Aetna Executive Chairman John W. Rowe, M.D. “Aetna has made both issues top priorities, launching highly
Analysts Calling A Bottom On Wyeth
Forbes - Wyeth (nyse: WYE - news - people ) also awaits FDA action on depression treatment desvenlafaxine, which was submitted for approval last December. Wyeth is expected to file for approval of bifeprunox for schizophrenia and